Phosphotyrosyl mimetics in the development of signal transduction inhibitors

被引:121
作者
Burke, TR [1 ]
Lee, K [1 ]
机构
[1] NCI, Med Chem Lab, Canc Res Ctr, NIH, Frederick, MD 21701 USA
关键词
D O I
10.1021/ar020127o
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Phosphotyrosyl (pTyr) residues play important roles in cellular signal transduction by facilitating recognition and binding necessary for critical protein-protein interactions, and for this reason pTyr motifs represent attractive starting points in the development of signaling antagonists. Although the pTyr phosphoryl moiety is central in these phenomena, its incorporation into signaling inhibitors is contraindicated due to enzymatic lability and limited bioavailabilty associated with phosphate esters. To address these limiations, an entire field of study has arisen devoted to the design and utilization of pTyr mimetics. This Account provides a perspective on the roles of pTyr residues in signal transduction and approaches to pTyr mimetic development.
引用
收藏
页码:426 / 433
页数:8
相关论文
共 86 条
  • [1] The structure and mechanism of protein phosphatases: Insights into catalysis and regulation
    Barford, D
    Das, AK
    Egloff, MP
    [J]. ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1998, 27 : 133 - 164
  • [2] Ligands for the tyrosine kinase p56lck SH2 domain:: Discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements
    Beaulieu, PL
    Cameron, DR
    Ferland, JM
    Gauthier, J
    Ghiro, E
    Gillard, J
    Gorys, V
    Poirier, M
    Rancourt, J
    Wernic, D
    Llinas-Brunet, M
    Betageri, R
    Cardozo, M
    Hickey, ER
    Ingraham, R
    Jakes, S
    Kabcenell, A
    Kirrane, T
    Lukas, S
    Patel, U
    Proudfoot, J
    Sharma, R
    Tong, L
    Moss, N
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (10) : 1757 - 1766
  • [3] BLACKBURN GM, 1981, CHEM IND-LONDON, P134
  • [4] THE SYNTHESIS OF ALPHA-FLUOROALKYLPHOSPHONATES
    BLACKBURN, GM
    PARRATT, MJ
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1983, (16) : 886 - 888
  • [5] Oncogenic kinase signalling
    Blume-Jensen, P
    Hunter, T
    [J]. NATURE, 2001, 411 (6835) : 355 - 365
  • [6] X-ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor
    Bohacek, RS
    Dalgarno, DC
    Hatada, M
    Jacobsen, VA
    Lynch, BA
    Macek, KJ
    Merry, T
    Metcalf, CA
    Narula, SS
    Sawyer, TK
    Shakespeare, WC
    Violette, SM
    Weigele, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) : 660 - 663
  • [7] Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase
    Bradshaw, JM
    Mitaxov, V
    Waksman, G
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 293 (04) : 971 - 985
  • [8] Burke TR, 2001, BIOPOLYMERS, V60, P32, DOI 10.1002/1097-0282(2001)60:1<32::AID-BIP1002>3.0.CO
  • [9] 2-I
  • [10] Monocarboxylic-based phosphotyrosyl mimetics in the design of Grb2 SH2 domain inhibitors
    Burke, TR
    Luo, J
    Yao, ZJ
    Gao, Y
    Zhao, H
    Milne, GWA
    Guo, RB
    Voigt, JH
    King, CR
    Yang, DJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (03) : 347 - 352